{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:25:35Z","timestamp":1771237535758,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["102\/IFD\/SAN\/5131\/2011-2012"],"award-info":[{"award-number":["102\/IFD\/SAN\/5131\/2011-2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["102\/IFD\/SAN\/5131\/2011-2012"],"award-info":[{"award-number":["102\/IFD\/SAN\/5131\/2011-2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.intimp.2017.12.028","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T13:51:20Z","timestamp":1514987480000},"page":"297-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Blocking osteopontin-fibronectin interactions reduce extracellular fibronectin deployment and arthritic immunopathology"],"prefix":"10.1016","volume":"55","author":[{"given":"Brij Bhushan","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saniya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh K.","family":"Vasishta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh K.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manni","family":"Luthra-Guptasarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2017.12.028_bb0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2017.12.028_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ncprheum0094","article-title":"Even though T-cell-directed trials have been of limited success, is there reason for optimism?","volume":"2","author":"Panayi","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2017.12.028_bb0015","first-page":"30","article-title":"Role of synovial fibroblasts in rheumatoid arthritis","volume":"21","author":"Lefevre","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.intimp.2017.12.028_bb0020","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/rheumatology\/keg413","article-title":"Why do leucocytes accumulate within chronically inflamed joints?","volume":"42","author":"Buckley","year":"2003","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2017.12.028_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI114957","article-title":"Integrins","volume":"87","author":"Ruoslahti","year":"1991","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.intimp.2017.12.028_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(92)90115-S","article-title":"Integrins: versatility, modulation, and signaling in cell adhesion","volume":"69","author":"Hynes","year":"1992","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2017.12.028_bb0035","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0955-0674(02)00361-7","article-title":"Matricellular proteins: extracellular modulators of cell function","volume":"14","author":"Bornstein","year":"2002","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.intimp.2017.12.028_bb0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI12609","article-title":"The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?","volume":"107","author":"Murphy-Ullrich","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.intimp.2017.12.028_bb0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2613.2000.00163.x","article-title":"Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation","volume":"81","author":"O'regan","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2017.12.028_bb0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI117718","article-title":"The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro","volume":"95","author":"Liaw","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2017.12.028_bb0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.matbio.2005.05.005","article-title":"Distinct structural requirements for binding of the integrins \u03b1v\u03b26, \u03b1v\u03b23, \u03b1v\u03b25, \u03b15\u03b21 and \u03b19\u03b21 to osteopontin","volume":"24","author":"Yokosaki","year":"2005","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.intimp.2017.12.028_bb0060","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1091\/mbc.9.6.1425","article-title":"Identification of osteopontin as a novel ligand for the integrin \u03b18\u03b21 and potential roles for this integrin\u2013ligand interaction in kidney morphogenesis","volume":"9","author":"Denda","year":"1998","journal-title":"Mol. Biol. Cell"},{"issue":"51","key":"10.1016\/j.intimp.2017.12.028_bb0065","doi-asserted-by":"crossref","first-page":"36328","DOI":"10.1074\/jbc.274.51.36328","article-title":"The integrin \u03b19\u03b21 binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin","volume":"274","author":"Yokosaki","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2017.12.028_bb0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1091\/mbc.5.5.565","article-title":"Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain","volume":"5","author":"Senger","year":"1994","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.intimp.2017.12.028_bb0075","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.10143","article-title":"Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis","volume":"46","author":"Ohshima","year":"2002","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2017.12.028_bb0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI17778","article-title":"Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis","volume":"112","author":"Yamamoto","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.intimp.2017.12.028_bb0085","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1002\/art.25020","article-title":"Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6","volume":"60","author":"Take","year":"2009","journal-title":"Arthritis Rheumatol."},{"issue":"9","key":"10.1016\/j.intimp.2017.12.028_bb0090","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2017.12.028_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069343","article-title":"Fibrotic remodeling of the extracellular matrix through a novel (engineered, dual-function) antibody reactive to a cryptic epitope on the N-terminal 30kDa fragment of fibronectin","volume":"8","author":"Sharma","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2017.12.028_bb0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1167\/iovs.14-14934","article-title":"Targeting the fibronectin type III repeats in tenascin-C inhibits epithelial\u2013mesenchymal transition in the context of posterior capsular opacification targeting fibrotic pathologies","volume":"56","author":"Tiwari","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2017.12.028_bb0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jbbm.2003.12.004","article-title":"A rapid method for fibronectin purification on nitrocellulose membranes suitable for tissue culture","volume":"59","author":"Chifflet","year":"2004","journal-title":"J. Biochem. Biophys. Methods"},{"issue":"2","key":"10.1016\/j.intimp.2017.12.028_bb0110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.134.2.573","article-title":"Altered rate of fibronectin matrix assembly by deletion of the first type III repeats","volume":"134","author":"Sechler","year":"1996","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.intimp.2017.12.028_bb0115","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/nprot.2006.393","article-title":"Collagen antibody-induced arthritis","volume":"1","author":"Khachigian","year":"2006","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.intimp.2017.12.028_bb0120","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.4049\/jimmunol.169.11.6588","article-title":"Rapid induction of apoptosis in CD8+ HIV-1 envelope-specific murine CTLs by short exposure to antigenic peptide","volume":"169","author":"Takahashi","year":"2002","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2017.12.028_bb0125","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1073\/pnas.052523599","article-title":"Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice","volume":"99","author":"Yumoto","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2017.12.028_bb0130","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar2941","article-title":"Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage","volume":"12","author":"Garc\u00eda","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2017.12.028_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ki.2009.90","article-title":"Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney","volume":"76","author":"Wolak","year":"2009","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.intimp.2017.12.028_bb0140","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.intimp.2007.06.009","article-title":"Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody","volume":"7","author":"Yamamoto","year":"2007","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2017.12.028_bb0145","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/jcs.111.9.1165","article-title":"Osteopontin is a ligand for the alpha4beta1 integrin","volume":"111","author":"Bayless","year":"1998","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.intimp.2017.12.028_bb0150","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/ar593","article-title":"VLA-4-dependent and-independent pathways in cell contact-induced proinflammatory cytokine production by synovial nurse-like cells from rheumatoid arthritis patients","volume":"4","author":"Takeuchi","year":"2002","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.intimp.2017.12.028_bb0155","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1517\/14712598.7.9.1287","article-title":"B-cell targeting: a novel approach to immune intervention today and tomorrow","volume":"7","author":"D\u00f6rner","year":"2007","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2017.12.028_bb0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2017.12.028_bb0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/pr.114.009639","article-title":"Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases","volume":"67","author":"Siebert","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2017.12.028_bb0170","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-3083.1990.tb02802.x","article-title":"Cellular fibronectin in rheumatoid synovium and synovial fluid: a possible factor contributing to lymphocytic infiltration","volume":"31","author":"Walle","year":"1990","journal-title":"Scand. J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2017.12.028_bb0175","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/rheumatology\/40.7.739","article-title":"Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction","volume":"40","author":"Shiozawa","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.intimp.2017.12.028_bb0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejphar.2011.01.041","article-title":"A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in mice","volume":"657","author":"Fan","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2017.12.028_bb0185","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrm1940","article-title":"Harnessing actin dynamics for clathrin-mediated endocytosis","volume":"7","author":"Kaksonen","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5957","key":"10.1016\/j.intimp.2017.12.028_bb0190","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1175862","article-title":"Actin, a central player in cell shape and movement","volume":"326","author":"Pollard","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.intimp.2017.12.028_bb0195","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-biophys-051309-103849","article-title":"Control of actin filament treadmilling in cell motility","volume":"39","author":"Bugyi","year":"2010","journal-title":"Annu. Rev. Biophys."},{"issue":"4","key":"10.1016\/j.intimp.2017.12.028_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0010048","article-title":"Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis","volume":"1","author":"Aidinis","year":"2005","journal-title":"PLoS Genet."},{"key":"10.1016\/j.intimp.2017.12.028_bb0205","article-title":"Intracellular apoptotic pathways: a potential target for reducing joint damage in rheumatoid arthritis","author":"Williams","year":"2017","journal-title":"Inflamm. Res."},{"issue":"7","key":"10.1016\/j.intimp.2017.12.028_bb0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00011-005-1355-8","article-title":"Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines","volume":"54","author":"Herman","year":"2005","journal-title":"Inflamm. Res."},{"issue":"8","key":"10.1016\/j.intimp.2017.12.028_bb0215","doi-asserted-by":"crossref","first-page":"12649","DOI":"10.18632\/oncotarget.15172","article-title":"Dishevelled2 promotes apoptosis and inhibits inflammatory cytokine secretion in rheumatoid arthritis fibroblast-like synoviocytes through crosstalk with the NF-\u03baB pathway","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917305015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917305015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:10:41Z","timestamp":1761585041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576917305015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":43,"alternative-id":["S1567576917305015"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.12.028","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking osteopontin-fibronectin interactions reduce extracellular fibronectin deployment and arthritic immunopathology","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}